Page last updated: 2024-10-22

amsacrine and Leukemia, Lymphocytic, T Cell

amsacrine has been researched along with Leukemia, Lymphocytic, T Cell in 2 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chavalitshewinkoon, P1
Wilairat, P1
Gamage, S1
Denny, W1
Figgitt, D1
Ralph, R1
Snow, K1
Judd, W1

Other Studies

2 other studies available for amsacrine and Leukemia, Lymphocytic, T Cell

ArticleYear
Structure-activity relationships and modes of action of 9-anilinoacridines against chloroquine-resistant Plasmodium falciparum in vitro.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:3

    Topics: Amsacrine; Animals; Antimalarials; Cell Line; Chloroquine; Drug Resistance, Microbial; Humans; Leuke

1993
Characterisation of adriamycin- and amsacrine-resistant human leukaemic T cell lines.
    British journal of cancer, 1991, Volume: 63, Issue:1

    Topics: Amsacrine; Clone Cells; Cytotoxicity, Immunologic; DNA Damage; DNA-Binding Proteins; DNA, Neoplasm;

1991